Fintech
Investments in financial technology solutions, including digital payments, blockchain finance, and banking innovation.
173 Investors with Fintech industry focus

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

FGI FinTech Global Incorporated is dedicated to addressing corporate and societal challenges through innovative finance and solutions. The firm focuses on providing cutting-edge financial services and solutions to meet the evolving needs of businesses and communities. Established in 1994 and headquartered in Tokyo, Japan, FGI is listed on the Tokyo Stock Exchange and is a member of the Japan Business Federation (Keidanren).

Foresite Capital is a multi-stage healthcare and life sciences investment firm dedicated to addressing significant unmet needs by funding promising businesses at all stages of their life cycles. The firm employs a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Foresite Capital focuses on breakthrough opportunities at the intersection of technology and biotech, systematically identifying key undercurrents driving change.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.
KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Research Corporation Technologies (RCT) is a technology investment and management company based in Tucson, Arizona. Founded in 1987, RCT provides early-stage funding and development for promising biomedical companies and technologies, focusing on innovations originating from universities and research institutions worldwide. With assets exceeding $500 million, RCT advances technology development through venture investments, partnerships, and special licensing programs, supporting the commercialization of academic innovations.

Venture Investors is a leading venture capital firm based in the Midwest, focusing on healthcare innovations. With access to renowned research universities and vibrant communities, the firm targets and invests in groundbreaking ideas that shape the future of health and wellness. They manage $275 million in assets and have a proven track record of success in driving healthcare advancements.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Camino Real Capital Partners, LLC (CRCP) is a private investment firm based in Santa Fe, New Mexico, dedicated to investing in America's leading innovators and emerging technologies. The firm emphasizes building relationships, fostering growth opportunities, and creating value. CRCP focuses on transformative technology, emerging medical devices, life science innovations, and cutting-edge service providers in the energy sector. The firm invests its own capital alongside a network of accredited co-venturers, providing technology and marketing insights and management guidance to early-stage innovators.

Glynn Capital is a private and public technology investment firm focused on long-term investments in technology growth companies. The firm aims to partner with exceptional teams leveraging disruptive technologies to address markets ripe for change. Glynn Capital invests in both private early-growth stage companies and public durable growth companies, seeking to add value through experience and networks.

Black Diamond Ventures (BDV) is a transformational venture capital firm with over two decades of experience in hybrid investing. Founded by Chris Lucas, BDV focuses on multi-stage investments in biotech, deep tech, and med tech sectors, supporting visionary founders with strategic and operational guidance. The firm is committed to building relationships among investors and their investments, helping founders reach the next level through a network of partners and strategic opportunities.
Escalate Capital Partners is a prominent private credit and growth equity investment firm focusing on rapidly growing later-stage companies in the technology, software, services, and healthcare sectors. With a robust investment history, the firm has deployed $1.3 billion to accelerate growth while minimizing dilution for management and equity holders. The firm prides itself on providing stable and tailored capital solutions, backed by an experienced investment team with over 100 years of combined expertise, having invested over $2 billion in more than 500 companies.

City Side Ventures is a dynamic venture group established in 2015, focused on transforming early-stage capital deployment in Michigan. The firm is driven by experienced business builders, serial entrepreneurs, and technologists, aiming to elevate Michigan's startup ecosystem by building a network of innovative investors. City Side Ventures emphasizes investing in the 'driver' (the founder) rather than the 'car' (the business), and is committed to integrity, courage, impact, responsibility, and velocity in its operations.

Norwest Venture Partners is a multi-stage investment firm with a history of delivering top quartile returns over the past 60 years. The firm focuses on partnering with founder-managed or capital-efficient businesses, helping them scale from double-digit to triple-digit revenues. Norwest has navigated various economic cycles and remains committed to building strong relationships with its portfolio companies, emphasizing trust and cultural alignment.

Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI
Medical Technology Enterprise Consortium (MTEC)
The Power of IP: Why It Matters to MTEC and Our Mission
MTEC President highlights intellectual property as essential to protecting innovation, attracting investment, and enabling collaboration. A new partnership with Patenter.io supports members in managing and commercializing IP.
George Mason University
SMART-US Wearable Ultrasound + AI Device for Muscle Force Prediction
AI-powered ultrasound in a wearable—SMART-US delivers lab-grade muscle-force insights anywhere.